跳至主要内容
临床试验/NCT06684535
NCT06684535已完成不适用

Role of Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain: A Randomized Controlled Trial

Tanta University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年11月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Time to the 1st rescue analgesia

研究概览

简要总结

This study aims to evaluate the role of dexmedetomidine as an adjuvant in external oblique intercostal plane block for post-thoracotomy pain.

详细描述

External oblique intercostal plane block (EOIPB) is a novel block that has been described as an important modification of the fascial plane blocks that can consistently involve the upper lateral abdominal walls.

Dexmedetomidine is a selective alpha 2- adrenoceptor agonist possessing sedative, anxiolytic, and analgesic properties without the development of respiratory depression.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status I-III.
  • Scheduled for open thoracotomy.

排除标准

  • Patients with neurological or intellectual disability.
  • Infection at the injection site.
  • Drug abuse.
  • Allergic reaction to local anesthetics.
  • Coagulation abnormalities.
  • Pregnancy.
  • Body Mass Index (BMI) ≥35 kg/m
  • Severe cardiovascular problems.
  • Diabetic neuropathy.

研究组 & 干预措施

Dexmedetomidine group

Experimental

Patients will receive 29 ml bupivacaine 0.25% + 1 ml dexmedetomidine 0.5 μg/kg.

干预措施: Dexmedetomidine (Drug)

Control group

Active Comparator

Patients will receive 29 ml bupivacaine 0.25% + 1 ml saline.

干预措施: Saline (Drug)

结局指标

主要结局

Time to the 1st rescue analgesia

时间窗: 48 hours postoperatively

Time to the first request for the rescue analgesia (time from end of surgery to first dose of morphine administrated) will be recorded.

次要结局

  • Intraoperative fentanyl consumption(Intraoperatively)
  • Total morphine consumption(48 hours postoperatively)
  • Degree of pain(48 hours postoperatively)
  • Heart rate(Every 15 min till the end of surgery)
  • Mean arterial pressure(Every 15 min till the end of surgery)
  • Incidence of adverse events(48 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohammed Said ElSharkawy

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

研究点 (1)

Loading locations...

相似试验